THC BIOMED: Don Shaxon Joins Advisory Board.
(firmenpresse) - THC BIOMED: Don Shaxon Joins Advisory Board.
Vancouver, B.C. - (July 22, 2015) THC BioMed Intl Ltd. (THC) is pleased to announce it has appointed Don Shaxon to the Companys newly formed Advisory Board. Mr. Shaxon brings 20 years experience in the capital markets including a successful position as Corporate development Manager with Cannabis Science Inc. where he was instrumental in helping build the company from a small cap company into an industry leader with a market cap that topped $100 million.
The Company has granted 500,000 incentive stock options to Mr. Shaxon, 250,000 at a price of $0.10 per share and 250,000 at a price of $0.15 per share with an exercise period of two years. The options vest over the course of one year, with 25% vesting on the date of grant and 25% every 4 months following the date of grant.
THCs vision is to be on the leading edge of scientific research and development of products and services related to the medical cannabis industry while creating a standard of excellence. As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry.
Please visit our website for a more detailed description of our business and services available. www.thcbiomed.com
President and CEO:
John Miller
THC Biomed Intl Ltd. T: 604 682-1643E: info(at)thcbiomed.com
THC BIOMED INTL LTD.
Suite 1100 - 888 Dunsmuir StreetVancouver, BC V6C 3K4
www.thcbiomed.com
THC.CSE
THCBF-OTC
TFHC.F
Forward-Looking Information:
This press release contains certain forward-looking information within the meaning of applicable securities law. The forward looking statements include that (i) Mr. Reynolds will be instrumental in helping the Company achieve its goal of global growth and (ii) As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Forward-looking information is frequently characterized by words such as plan, expect, project, intend, believe, anticipate, estimate, may, will, would, potential, proposed and other similar words, or statements that certain events or conditions may or will occur. These statements are only predictions. These statements are based on expectations and assumptions made by the management of THC at the date the information is provided, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. For a description of the risks and uncertainties facing THC and its business and affairs, readers should refer to THCs Listing Statement, Financial Statements and its Managements Discussion and Analysis on www.sedar.com.
Leseranfragen:
Datum: 22.07.2015 - 14:02 Uhr
Sprache: Deutsch
News-ID 408379
Anzahl Zeichen: 3095
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 179 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"THC BIOMED: Don Shaxon Joins Advisory Board.
"
steht unter der journalistisch-redaktionellen Verantwortung von
THC BioMed Intl Ltd. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
